Prediction of pertussis vaccine efficacy using a correlates of protection model

This publication has 8 references indexed in Scilit:

• A Framework for Assessing Immunological Correlates of Protection in Vaccine Trials
  The Journal of Infectious Diseases, 2007
• Use of statistical models for evaluating antibody response as a correlate of protection against varicella
  Statistics in Medicine, 2002
• A search for serologic correlates of immunity to Bordetella pertussis cough illnesses
  Vaccine, 1998
• Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis
  Vaccine, 1998
• Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine
  The Lancet, 1997
• A Controlled Trial of a Two-Component Acellular, a Five-Component Acellular, and a Whole-Cell Pertussis Vaccine
  New England Journal of Medicine, 1996
• Surrogate endpoints in clinical trials: Definition and operational criteria
  Statistics in Medicine, 1989
• PLACEBO-CONTROLLED TRIAL OF TWO ACELLULAR PERTUSSIS VACCINES IN SWEDEN—PROTECIVE EFFICACY AND ADVERSE EVENTS
  The Lancet, 1988